227 related articles for article (PubMed ID: 34477069)
21. Cutaneous mastocytosis in adults. evaluation of 14 patients with respect to systemic disease manifestations.
Tebbe B; Stavropoulos PG; Krasagakis K; Orfanos CE
Dermatology; 1998; 197(2):101-8. PubMed ID: 9732155
[TBL] [Abstract][Full Text] [Related]
22. Telangiectasia macularis eruptiva perstans, a form of cutaneous mastocytosis, associated with malignant melanoma.
Kowalzic L; Eickenscheidt L; Seidel C; Kribus S; Ziegler H; Komar M
J Dtsch Dermatol Ges; 2009 Apr; 7(4):360-2. PubMed ID: 19054427
[TBL] [Abstract][Full Text] [Related]
23. Telangiectasia Macularis Eruptiva Perstans in a 55-Year-Old Female With Type 2 Diabetes Mellitus.
Alhammad NS; Alshehri S; Alawadi TM; Ragaban A; Alyahya FS; Alharbi A
Cureus; 2024 Mar; 16(3):e57333. PubMed ID: 38690480
[TBL] [Abstract][Full Text] [Related]
24. Sustained improvement in urticaria pigmentosa and pruritus in a case of indolent systemic mastocytosis treated with cladribine.
Lock AD; McNamara CJ; Rustin MH
Clin Exp Dermatol; 2015 Mar; 40(2):142-5. PubMed ID: 25515765
[TBL] [Abstract][Full Text] [Related]
25. Cutaneous mastocytosis in childhood.
Nemat K; Abraham S
Allergol Select; 2022; 6():1-10. PubMed ID: 35028497
[TBL] [Abstract][Full Text] [Related]
26. Urticaria pigmentosa and systemic mastocytosis.
Keow J; Chin-Yee B; Hsia CC; Robertson K
Clin Case Rep; 2023 Dec; 11(12):e8302. PubMed ID: 38111510
[TBL] [Abstract][Full Text] [Related]
27. The skin in mastocytosis.
Soter NA
J Invest Dermatol; 1991 Mar; 96(3 Suppl):32S-38S; discussion 38S-39S, 60S-65S. PubMed ID: 16799606
[TBL] [Abstract][Full Text] [Related]
28. Presentation of telangiectasia macularis eruptiva perstans as a long-standing solitary plaque associated with renal carcinoma.
Pascual JC; Bañuls J; Albares MP; Vergara G; Belinchón I; Silvestre JF; Betlloch I
J Cutan Med Surg; 2003; 7(5):399-402. PubMed ID: 14973646
[TBL] [Abstract][Full Text] [Related]
29. Expression of the basophil-specific antibodies 2D7 and BB1 in patients with cutaneous Mastocytosis.
Idoate MA; Echeveste J; Gil P; Sanz ML; Ferrer M
J Investig Allergol Clin Immunol; 2013; 23(6):392-7. PubMed ID: 24459815
[TBL] [Abstract][Full Text] [Related]
30. Erythrodermic mastocytosis.
Requena L
Cutis; 1992 Mar; 49(3):189-92. PubMed ID: 1533360
[TBL] [Abstract][Full Text] [Related]
31. Treatment of chronic autoimmune urticaria with omalizumab.
Kaplan AP; Joseph K; Maykut RJ; Geba GP; Zeldin RK
J Allergy Clin Immunol; 2008 Sep; 122(3):569-73. PubMed ID: 18774392
[TBL] [Abstract][Full Text] [Related]
32. Omalizumab may not inhibit mast cell and basophil activation in vitro.
Gericke J; Ohanyan T; Church MK; Maurer M; Metz M
J Eur Acad Dermatol Venereol; 2015 Sep; 29(9):1832-6. PubMed ID: 25257818
[TBL] [Abstract][Full Text] [Related]
33. [Mastocytosis in children].
Wassmer H; Hartmann K
Dermatologie (Heidelb); 2023 May; 74(5):323-329. PubMed ID: 37140636
[TBL] [Abstract][Full Text] [Related]
34. Efficacy of Omalizumab in Mastocytosis: Allusive Indication Obtained from a Prospective, Double-Blind, Multicenter Study (XOLMA Study).
Distler M; Maul JT; Steiner UC; Jandus P; Kolios AGA; Murer C; Graf N; Seebach JD; Pichler WJ; Navarini AA; French LE; Helbling A; Schmid-Grendelmeier P
Dermatology; 2020; 236(6):529-539. PubMed ID: 31958790
[TBL] [Abstract][Full Text] [Related]
35. Large maculopapular cutaneous lesions are associated with favorable outcome in childhood-onset mastocytosis.
Wiechers T; Rabenhorst A; Schick T; Preussner LM; Förster A; Valent P; Horny HP; Sotlar K; Hartmann K
J Allergy Clin Immunol; 2015 Dec; 136(6):1581-1590.e3. PubMed ID: 26152315
[TBL] [Abstract][Full Text] [Related]
36. Ringed telangiectasias: an unusual presentation of telangiectasia macularis eruptiva perstans.
Siddique L; Ahrns H; Seiverling E
BMJ Case Rep; 2017 Nov; 2017():. PubMed ID: 29196283
[TBL] [Abstract][Full Text] [Related]
37. Telangiectasia macularis eruptive perstans successfully treated with PUVA therapy.
Sotiriou E; Apalla Z; Ioannides D
Photodermatol Photoimmunol Photomed; 2010 Feb; 26(1):46-7. PubMed ID: 20070840
[TBL] [Abstract][Full Text] [Related]
38. Studies on histamine metabolism in mastocytosis.
Granerus G; Olafsson JH; Roupe G
J Invest Dermatol; 1983 May; 80(5):410-6. PubMed ID: 6841997
[TBL] [Abstract][Full Text] [Related]
39. Diagnosis and treatment of cutaneous mastocytosis in children: practical recommendations.
Castells M; Metcalfe DD; Escribano L
Am J Clin Dermatol; 2011 Aug; 12(4):259-70. PubMed ID: 21668033
[TBL] [Abstract][Full Text] [Related]
40. Symptomatic response to imatinib mesylate in cutaneous mastocytosis associated with chronic myelomonocytic leukemia.
Vannorsdall EJ; Collins JA; Chen QC; Sarai G; Baer MR
Curr Oncol; 2013 Aug; 20(4):e349-53. PubMed ID: 23904774
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
